Naltrexone in alcohol dependence
- PMID: 9105212
Naltrexone in alcohol dependence
Abstract
Naltrexone is a narcotic antagonist that has been shown to reduce alcohol craving and alcohol use in patients with alcohol dependence. It should not be used as exclusive treatment but only as an adjunct to a comprehensive program that includes psychologic and social treatment approaches such as those in Alcoholics Anonymous or professional programs. The two most serious complications of naltrexone therapy are the precipitation of narcotic withdrawal in patients taking narcotics, and hepatotoxicity. The latter complication occurs only at dosages much higher than the 50 mg per day recommended for treatment of alcohol dependence. Alcohol is known to enhance opioid receptors. Evidently, naltrexone blockade of these receptors results in reduced craving for alcohol, less of a "high" while drinking and less alcohol use.
Similar articles
-
Naltrexone for the treatment of alcoholism.Am Fam Physician. 1997 Sep 1;56(3):803-6. Am Fam Physician. 1997. PMID: 9301573 Review.
-
Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.Alcohol Alcohol. 1995 Nov;30(6):789-98. Alcohol Alcohol. 1995. PMID: 8679021 Review.
-
Effect of naltrexone on human alcohol consumption.J Clin Psychiatry. 1995;56 Suppl 7:24-9. J Clin Psychiatry. 1995. PMID: 7673102 Review.
-
Naltrexone in the treatment of alcohol dependence.N Engl J Med. 2001 Dec 13;345(24):1734-9. doi: 10.1056/NEJMoa011127. N Engl J Med. 2001. PMID: 11742047 Clinical Trial.
-
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.Psychopharmacology (Berl). 2002 Feb;160(1):19-29. doi: 10.1007/s002130100919. Epub 2002 Jan 22. Psychopharmacology (Berl). 2002. PMID: 11862370 Clinical Trial.
Cited by
-
Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.Psychopharmacology (Berl). 2004 Apr;173(1-2):210-6. doi: 10.1007/s00213-003-1694-5. Epub 2003 Dec 9. Psychopharmacology (Berl). 2004. PMID: 14663553
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical